These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11309253)

  • 41. Morphine-induced conditioned place preference in rats is inhibited by electroacupuncture at 2 Hz: role of enkephalin in the nucleus accumbens.
    Liang J; Ping XJ; Li YJ; Ma YY; Wu LZ; Han JS; Cui CL
    Neuropharmacology; 2010 Jan; 58(1):233-40. PubMed ID: 19596017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic alcohol administration combined with repeated re-exposures and withdrawals.
    Lallemand F; Soubrié P; De Witte P
    Alcohol Alcohol; 2004; 39(6):486-92. PubMed ID: 15466898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception.
    Katsuyama S; Mizoguchi H; Kuwahata H; Komatsu T; Nagaoka K; Nakamura H; Bagetta G; Sakurada T; Sakurada S
    Eur J Pain; 2013 May; 17(5):664-75. PubMed ID: 23138934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.
    Dodu JC; Moncayo RK; Damaj MI; Schlosburg JE; Akbarali HI; O'Brien LD; Kendall DA; Wu Z; Lu D; Lichtman AH
    J Pharmacol Exp Ther; 2022 Jan; 380(1):1-14. PubMed ID: 34625464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats.
    Rowland NE; Mukherjee M; Robertson K
    Psychopharmacology (Berl); 2001 Dec; 159(1):111-6. PubMed ID: 11797078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats.
    Georges F; Caillé S; Vouillac C; Le Moine C; Stinus L
    Eur J Neurosci; 2005 Oct; 22(7):1812-6. PubMed ID: 16197523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrathecal delivery of a mutant micro-opioid receptor activated by naloxone as a possible antinociceptive paradigm.
    Kao JH; Chen SL; Ma HI; Law PY; Tao PL; Loh HH
    J Pharmacol Exp Ther; 2010 Sep; 334(3):739-45. PubMed ID: 20554907
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study of cannabinoid dependence in animals.
    Maldonado R
    Pharmacol Ther; 2002 Aug; 95(2):153-64. PubMed ID: 12182962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.
    Bisaga A; Comer SD; Ward AS; Popik P; Kleber HD; Fischman MW
    Psychopharmacology (Berl); 2001 Aug; 157(1):1-10. PubMed ID: 11512037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of opioid and cannabinoid receptor antagonism on orphanin FQ-induced hyperphagia in rats.
    Pietras TA; Rowland NE
    Eur J Pharmacol; 2002 May; 442(3):237-9. PubMed ID: 12065077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Male and female rats show opiate withdrawal-induced place aversion and extinction in a Y-maze paradigm.
    Fournier ML; Faugere A; Barba-Vila O; Le Moine C
    Behav Brain Res; 2023 Feb; 437():114122. PubMed ID: 36174840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabinoidergic and opioidergic inhibition of spinal reflexes in the decerebrated, spinalized rabbit.
    Clarke RW; Harris J; Jenkins S; Witton SK
    Neuropharmacology; 2001 Mar; 40(4):570-7. PubMed ID: 11249966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats.
    Serra S; Brunetti G; Pani M; Vacca G; Carai MA; Gessa GL; Colombo G
    Eur J Pharmacol; 2002 May; 443(1-3):95-7. PubMed ID: 12044797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoantibodies against opioid or glutamate receptors are associated with changes in morphine reward and physical dependence in mice.
    Capone F; Adriani W; Shumilina M; Izykenova G; Granstrem O; Dambinova S; Laviola G
    Psychopharmacology (Berl); 2008 May; 197(4):535-48. PubMed ID: 18265961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB1 receptor antagonist, SR 141716.
    Vacca G; Serra S; Brunetti G; Carai MA; Gessa GL; Colombo G
    Eur J Pharmacol; 2002 Jun; 445(1-2):55-9. PubMed ID: 12065194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upregulation of dynorphin/kappa opioid receptor system in the dorsal hippocampus contributes to morphine withdrawal-induced place aversion.
    Chen Y; Wang CY; Zan GY; Yao SY; Deng YZ; Shu XL; Wu WW; Ma Y; Wang YJ; Yu CX; Liu JG
    Acta Pharmacol Sin; 2023 Mar; 44(3):538-545. PubMed ID: 36127507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats.
    Gallate JE; Mallet PE; McGregor IS
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):210-6. PubMed ID: 14663553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms.
    Jones JD; Luba RR; Vogelman JL; Comer SD
    Am J Addict; 2016 Jan; 25(1):41-8. PubMed ID: 26692286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history.
    Azolosa JL; Stitzer ML; Greenwald MK
    Psychopharmacology (Berl); 1994 Feb; 114(1):71-80. PubMed ID: 7846209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism.
    Ruiz F; Fournié-Zaluski MC; Roques BP; Maldonado R
    Br J Pharmacol; 1996 Sep; 119(1):174-82. PubMed ID: 8872371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.